iNFixion is awarded Gilbert Family Foundation grant to generate new NF1 preclinical models focused on neurocognition

The Gilbert Family Foundation has awarded a three-year grant to iNFixion Bioscience as part of its Next Generation Neurofibromatosis Models Initiative to develop a more human-translatable rodent model for the cognitive and learning deficits experienced by individuals with NF1.  This project builds on research from Dr. Jared Young’s lab at UCSD, which will conduct all rodent testing. Equivalent tests in both kids and young adults with NF1 will be performed by Dr. Karin Walsh at Children’s National Hospital in Washington, DC.  iNFixion will evaluate the NF1 protein levels and distribution in various rodent tissues and coordinate the overall development of what is targeted to be a new rodent model for use in NF1 drug discovery programs targeting neurocognitive symptoms in people living with NF1.

Learn more about the Gilbert Family Foundation’s Next Generation Neurofibromatosis Models Initiative here.